Company Profiles

driven by the PitchBook Platform

Falcon Genomics

Falcon Genomics
2004 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Grant LATEST DEAL TYPE
$510K LATEST DEAL AMOUNT
3 INVESTORS
Description

Provider of genotyping assays designed to offer accurate diagnosis of cancer and personalized formulation of therapeutic strategies. The company's genotyping assays are used to eliminate side effects of long-term ineffective therapy, enabling clinicians to accurately diagnose and treat breast cancer.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Biotechnology
Primary Office
2661 Clearview Road
Suite 1
Allison Park, PA 15101
United States

+1 (412) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Falcon Genomics’s full profile, request a free trial.

Falcon Genomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 03-Nov-2010 $510K 00000 Completed Generating Revenue
1. Early Stage VC 14-Aug-2007 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Falcon Genomics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Internal Revenue Service Government 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
Pittsburgh Life Sciences Greenhouse Venture Capital Minority 000 0000 000000 0

Falcon Genomics Executive Team (4)

Name Title Board
Seat
Contact
Info
Rula Abbud-Antaki Ph.D Co-Founder, Chief Scientific Officer, Owner & President
James Antaki Vice President

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com